Sanofi Website

Sanofi

ENXTPA-SAN

Basic

  • Market Cap

    €121.87B

  • EV

    €139.14B

  • Shares Out

    1,250.12M

  • Revenue

    €46.99B

  • Employees

    86,088

Margins

  • Gross

    68.68%

  • EBITDA

    24.02%

  • Operating

    17.8%

  • Pre-Tax

    11.87%

  • Net

    8.97%

  • FCF

    11.58%

Returns (5Yr Avg)

  • ROA

    6.04%

  • ROTA

    13.98%

  • ROE

    10.87%

  • ROCE

    8.9%

  • ROIC

    6.99%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €108.56

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    €6,795M

  • Net Debt

    €16.96B

  • Debt/Equity

    0.33

  • EBIT/Interest

    11.25

Growth (CAGR)

  • Rev 3Yr

    7.76%

  • Rev 5Yr

    5.03%

  • Rev 10Yr

    3.55%

  • Dil EPS 3Yr

    -9.85%

  • Dil EPS 5Yr

    3.36%

  • Dil EPS 10Yr

    0.81%

  • Rev Fwd 2Yr

    7.68%

  • EBITDA Fwd 2Yr

    4.31%

  • EPS Fwd 2Yr

    3.6%

  • EPS LT Growth Est

    7.43%

Dividends

  • Yield

    —

  • Payout

    111.61%

  • DPS

    €3.76

  • DPS Growth 3Yr

    5.52%

  • DPS Growth 5Yr

    4.14%

  • DPS Growth 10Yr

    2.99%

  • DPS Growth Fwd 2Yr

    3.95%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

36,126

36,041

37,761

42,997

43,070

44,092

Other Revenues, Total

1,505

1,328

1,414

2,392

2,963

2,894

Total Revenues

37,631

37,369

39,175

45,389

46,033

46,986

Total Revenues % Chg.

5.5%

-0.7%

4.8%

15.9%

1.4%

2%

Cost of Goods Sold, Total

11,976

12,106

12,251

13,692

14,216

14,718

Gross Profit

25,655

25,263

26,924

31,697

31,817

32,268

Selling General & Admin Expenses, Total

9,967

9,448

9,599

10,539

10,765

10,843

R&D Expenses

6,020

5,530

5,692

6,706

6,728

6,958

Amortization of Goodwill and Intangible Assets

2,146

1,681

1,580

1,827

2,172

2,198

Other Operating Expenses

720

1,025

1,488

1,587

2,950

3,907

Other Operating Expenses, Total

18,853

17,684

18,359

20,659

22,615

23,906

Operating Income

6,802

7,579

8,565

11,038

9,202

8,362

Interest Expense, Total

-544

-459

-362

-394

-527

-743

Interest And Investment Income

91

37

3

173

546

546

Net Interest Expenses

-453

-422

-359

-221

19

-197

Income (Loss) On Equity Invest.

255

359

39

68

-115

-76

Currency Exchange Gains (Loss)

1

-6

2

-4

-2

-2

Other Non Operating Income (Expenses)

236

144

70

37

-665

-710

EBT, Excl. Unusual Items

6,841

7,654

8,317

10,918

8,439

7,377

Restructuring Charges

-1,088

-1,089

-820

-1,336

-1,490

-2,274

Merger & Related Restructuring Charges

—

—

—

-3

-53

-4

-3

-20

-20

Gain (Loss) On Sale Of Investments

—

—

—

7,388

3

1

-1

-1

Gain (Loss) On Sale Of Assets

—

296

443

418

655

688

688

Asset Writedown

-3,604

-330

-192

228

-896

-510

Legal Settlements

—

—

—

—

—

327

—

—

—

—

—

Other Unusual Items

238

124

115

27

318

318

EBT, Incl. Unusual Items

3,007

14,137

7,837

10,490

7,038

5,578

Income Tax Expense

121

1,807

1,558

2,006

1,602

1,335

Earnings From Continuing Operations

2,886

12,330

6,279

8,484

5,436

4,243

Earnings Of Discontinued Operations

-101

—

—

—

—

—

Minority Interest

-31

-36

-56

-113

-36

-27

Net Income

2,754

12,294

6,223

8,371

5,400

4,216

Net Income to Common Incl Extra Items

2,754

12,294

6,223

8,371

5,400

4,216

Net Income to Common Excl. Extra Items

2,855

12,294

6,223

8,371

5,400

4,216

Total Shares Outstanding

1,253.8

1,250.7

1,252.5

1,252.6

1,251.3

1,250

Weighted Avg. Shares Outstanding

1,249.9

1,253.6

1,252.5

1,251.9

1,251.7

1,251.5

Weighted Avg. Shares Outstanding Dil

1,257.1

1,260.1

1,257.9

1,256.9

1,256.4

1,256.1

EPS

2.2

9.8

5

6.7

4.3

3.4

EPS Diluted

2.2

9.8

5

6.7

4.3

3.4

EBITDA

10,113

10,466

11,251

14,062

12,520

11,287

Effective Tax Rate

4%

12.8%

19.9%

19.1%

22.8%

23.9%